![Javier San Martin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Javier San Martin
Hoofd Techniek/Wetenschap/O&O bij
LEONABIO, INC.
Vermogen: 151 562 $ op 31-05-2026
Profiel
Op dit moment is Javier San Martin Chief Medical Officer bij Arrowhead Pharmaceuticals, Inc. Daarvoor was hij Executive Director-Bone Therapeutic Area bij Amgen, Inc., Principal bij Eli Lilly & Co., Senior VP-Global Clinical Development bij Ultragenyx Pharmaceutical, Inc. en Senior Vice President-Clinical Development bij Alder Biopharmaceuticals, Inc. Hij promoveerde aan de Universidad de Buenos Aires.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LEONABIO, INC. 0,17% | 01-05-2026 | 15.887 ( 0,17% ) | 151 562 $ | 31-05-2026 |
Actieve functies van Javier San Martin
| Bedrijven | Functie | Begin |
|---|---|---|
| LEONABIO, INC. | Hoofd Techniek/Wetenschap/O&O | 15-04-2024 |
Eerdere bekende functies van Javier San Martin
| Bedrijven | Functie | Einde |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-02-2024 |
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01-11-2019 |
| AMGEN INC. | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van Javier San Martin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
26
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
LeonaBio, Inc.
 LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
University of Buenos Aires School of Medicine
 University of Buenos Aires School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
